Global Research-Grade Genetic Testing Supply, Demand and Key Producers, 2023-2029

Global Research-Grade Genetic Testing Supply, Demand and Key Producers, 2023-2029

The global Research-Grade Genetic Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Research-grade genetic testing refers to basic research and drug development by scientists in genetics, mainly for researchers and research institutions.

This report studies the global Research-Grade Genetic Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Research-Grade Genetic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Research-Grade Genetic Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Research-Grade Genetic Testing total market, 2018-2029, (USD Million)

Global Research-Grade Genetic Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Research-Grade Genetic Testing total market, key domestic companies and share, (USD Million)

Global Research-Grade Genetic Testing revenue by player and market share 2018-2023, (USD Million)

Global Research-Grade Genetic Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Research-Grade Genetic Testing total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Research-Grade Genetic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Oxford Nanopore Technologies, Illumina, Ambry Genetics, Qiagen, PerkinElmer, BGI Group, Novogene and DaAn Gene, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Research-Grade Genetic Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Research-Grade Genetic Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Research-Grade Genetic Testing Market, Segmentation by Type
Whole Exome Sequencing (WES)
Whole Genome Sequencing (WGS)
Genome-Wide Association Studies (GWAS)
Others

Global Research-Grade Genetic Testing Market, Segmentation by Application
Complex Disease
Rare Disease
Genetic Diversity
Others

Companies Profiled:
Thermo Fisher Scientific
Oxford Nanopore Technologies
Illumina
Ambry Genetics
Qiagen
PerkinElmer
BGI Group
Novogene
DaAn Gene

Key Questions Answered

1. How big is the global Research-Grade Genetic Testing market?

2. What is the demand of the global Research-Grade Genetic Testing market?

3. What is the year over year growth of the global Research-Grade Genetic Testing market?

4. What is the total value of the global Research-Grade Genetic Testing market?

5. Who are the major players in the global Research-Grade Genetic Testing market?

6. What are the growth factors driving the market demand?